Document is current
Any future updates will be listed below
-
Authors
Frangieh, Chris J. https://orcid.org/0009-0007-3949-0085
Fan, Joy Linyue
Melms, Johannes C. https://orcid.org/0000-0002-5410-6586
Shah, Parin
Azizi, Elham https://orcid.org/0000-0001-5059-6971
Izar, Benjamin https://orcid.org/0000-0003-2379-6702
- License Information
-
More Information
Article History
Received: 9 December 2024
Accepted: 24 February 2026
First Online: 3 April 2026
Competing interests
: B.I. is a consultant for or received honoraria from Volastra Therapeutics, Johnson & Johnson/Janssen, Novartis, GSK, Eisai, AstraZeneca and Merck and has received research funding to Columbia University from Agenus, Alkermes, Arcus Biosciences, Checkmate Pharmaceuticals, Compugen, Immunocore, Regeneron and Synthekine. B.I. and C.J.F. are cofounders of Basima Therapeutics. The other authors do not have competing interests.
